B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 945 KRW -2.66% Market Closed
Market Cap: 504.3B KRW

BioNote Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioNote Inc
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Tax Provision
â‚©89B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Tax Provision
-â‚©108.6B
CAGR 3-Years
7%
CAGR 5-Years
-7%
CAGR 10-Years
-17%
SK Bioscience Co Ltd
KRX:302440
Tax Provision
â‚©15B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Tax Provision
-â‚©34.9B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Tax Provision
-â‚©24.5B
CAGR 3-Years
-51%
CAGR 5-Years
-55%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Tax Provision
-â‚©8.2m
CAGR 3-Years
70%
CAGR 5-Years
62%
CAGR 10-Years
N/A

BioNote Inc
Glance View

Market Cap
504.7B KRW
Industry
Biotechnology

BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.

Intrinsic Value
4 508.99 KRW
Overvaluation 9%
Intrinsic Value
Price
B

See Also

What is BioNote Inc's Tax Provision?
Tax Provision
89B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Tax Provision amounts to 89B KRW.

Back to Top